EBSCO Clinical Decisions Appoints Dr. Roy Ziegelstein as New Editor-in-Chief of DynaMed® | Martech Edge | Best News on Marketing and Technology
GFG image
EBSCO Clinical Decisions Appoints Dr. Roy Ziegelstein as New Editor-in-Chief of DynaMed®

marketing digital transformation

EBSCO Clinical Decisions Appoints Dr. Roy Ziegelstein as New Editor-in-Chief of DynaMed®

EBSCO Clinical Decisions Appoints Dr. Roy Ziegelstein as New Editor-in-Chief of DynaMed®

PRWeb

Published on : May 20, 2025

EBSCO Clinical Decisions has named Roy Ziegelstein, M.D., MACP, as the new Editor-in-Chief of DynaMed®, effective June 30, 2025. Dr. Ziegelstein brings over 30 years of leadership in medical education and healthcare, including his role as Vice Dean for Education at Johns Hopkins University School of Medicine.

Joining the DynaMed team marks an exciting new chapter for Dr. Ziegelstein, who looks forward to expanding his focus on medical education to a global clinical decision support platform. "The role of Editor-in-Chief at DynaMed will allow me to deliver evidence-based guidance to health professionals worldwide, collaborating with a diverse team to continuously push the boundaries of healthcare," he said.

Betsy Jones, EVP of EBSCO Clinical Decisions, praised Dr. Ziegelstein’s appointment as a transformative milestone, highlighting his expertise in medicine, education, and interdisciplinary research. As EBSCO advances its generative AI capabilities with Dyna AI, Dr. Ziegelstein’s leadership will be pivotal in enhancing the platform’s role as a trusted, reliable clinical resource.

EBSCO Clinical Decisions aims to improve patient care by providing clinicians with timely, evidence-based answers at the point of care. With Dr. Ziegelstein at the helm, DynaMed is set to further innovate in delivering clinical excellence powered by AI.

EBSCO Information Services is a global leader in online research content and search technologies, serving libraries, healthcare institutions, corporations, and governments. EBSCO’s AI-enabled solutions support clinical decision-making, research, and learning worldwide.